Digital program for weight loss and depression in adults over 50
Tests a digital program for weight and mood in adults with obesity and depression.
Key facts
- Who runs it
- University of Illinois Chicago
- Where
- Chicago and St Louis, United StatesSee the 2 sites
- Trial code
- Registry title
- Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older
- Status
- Recruiting
- People taking part
- 440 people, planned
- Started
- 21 Jan 2025
- Expected to end
- 13 Oct 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- vCare Intervention (6-month active treatment followed by 6-month maintenance)
- vCare Intervention (active treatment after 6 months)
- Record updated
- 18 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 50 to 74 from racial or ethnic minority groups who have both obesity and moderate depression. It tests a fully digital program for weight loss and depression.
- Age
- 50 to 74 years (inclusive)
- Sex
- All sexes can join.
- Disease stage
- Body mass index (BMI) from 27.0 up to less than 45.0, weight 396 lbs (180 kg) or less, and moderate to moderately severe depression (PHQ-9 score from 10 up to less than 20).
- Earlier treatment
- People cannot join if they are in an active weight loss program, take regular medicines that affect appetite or weight, or have had treatment for depression or another psychiatric condition. Bariatric surgery is not allowed unless it was more than 2 years ago.
Main reasons for not taking part
- Type 1 or type 2 diabetes, heart disease, stroke, or cancer treated in the past 12 months
- Bipolar or psychotic disorder, or active suicidal thoughts with a plan or intent
- Current or planned pregnancy, or breastfeeding (less than 6 months after birth)
- No reliable home Wi-Fi, or not able to speak and read English well enough to consent
- Weight change of more than 15 lbs (7 kg) in the past 3 months
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Age 50-74 years (inclusive)
- Confirmed body mass index (BMI) between ≥27.0 and <45.0 based on weight and height measured by study staff at device distribution
- Confirmed weight ≤396 lbs
- Patient Health Questionnaire-9 (PHQ-9) scores between ≥10 and <20, indicating moderate to moderately severe depressive symptoms
- Self-identified race and ethnicity other than non-Hispanic White
- Willing and able to accept randomization, and provide informed e-consent and HIPAA authorization
Who cannot take part
- Self-report of weight change >15 lbs. during prior 3 months
- Planned or prior bariatric surgery (Note: patients who are more than 2 years post bariatric surgery may otherwise be eligible)
- Participation in other behavioral, medical or surgical treatment studies by self-report that conflict with the primary weight loss and depression outcomes of this study
- Pre-existing type 1 or type 2 diabetes, coronary heart disease, heart failure, stroke, cancer diagnosis (other than non-melanoma skin cancer) or treatment in the past 12 months, end-stage organ failure, residence in a long-term care facility, life expectancy <24 months
- Taking prescription medications regularly that affect appetite/weight (e.g., anti-obesity medicines, oral corticosteroids, oral hypoglycemics, etc.) for chronic disease management
- Screen positive for bulimia nervosa using PHQ- eating disorder module
- Bipolar or psychotic disorder, or pharmacotherapy or psychotherapy (individual or professionally-led group therapy), or brain stimulation therapy for depression or any other psychiatric condition
- Cognitive impairment based on the Callahan 6-item screener
- Active alcohol or substance use disorder (including prescription drugs) based on the CAGE Questionnaire Adapted to Include Drugs (CAGE-AID)
- Unable to pass the Revised Physical Activity Readiness Questionnaire (PAR-Q) or obtain physician clearance to participate
- Unable to speak, read, understand English sufficiently for informed consent
- No reliable Wi-Fi Internet access at home
- Current active weight loss treatment, including research-based commercial weight loss programs (e.g., Weight Watchers, Jenny Craig, HMR, Omada, TOPS), other programs led by trained personnel (professional or lay) at the recruiting clinic or in the local community
- Active suicidal ideation (PHQ-9 item 9 score ≥1 or SCL-20 item 2 score ≥2) with active plan and/or intent
- Current or planned pregnancy or lactating (<6 months postpartum)
- Family/household member of an already enrolled participant or of a study team member
- Investigator discretion for serious safety or protocol adherence reasons
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 74 years old?
Where in United States
- Department of Medicine, Vitoux Program on Aging and PreventionChicago, United StatesContact: Jun Ma, MD, PhDTaking people
- Washington University School of Medicine in St. LouisSt Louis, United StatesContact: Thomas Kannampallil, PhDNot yet recruiting
About the trial
What the trial wants to find out
The goal of this randomized clinical trial is to test the efficacy of a fully digital intervention, combining the Lumen problem-solving therapy virtual coach for depression management with the Diabetes Prevention Program video-based program for weight loss, among racial and ethnic minorities with comorbid depression and obesity. The study aims include:
Read full original descriptionShow less
* Determine the efficacy of the vCare intervention at 6 months. Primary outcomes are weight and depression symptom checklist 20-item (SCL-20) score. * Identify predictors of treatment success, defined by achieving clinically significant weight loss (5%) and depression outcomes (50% decline or SCL-20<0.5), at 6 and 12 months. * Characterize participant experiences and perceptions of the vCare intervention. Eligible participants will be randomized to the early-intervention arm who will receive active treatment for 6 months, followed by maintenance for another 6 months, or the later-intervention arm who will be waitlisted for 6 months and then receive active treatment in the second 6 months.
The 2 groups in the trial
- Early VCare Intervention (6-month active treatment followed by 6-month maintenance)Treatment being tested
Participants randomized to the early-intervention arm will receive active treatment for 6 months, followed by maintenance for another 6 months.
Treatment: vCare Intervention (6-month active treatment followed by 6-month maintenance)
- Later Waitlist VCare Intervention (active treatment after 6 months)Existing treatment, for comparison
Participants in the later-intervention arm will be waitlisted for 6 months and then receive active treatment in the second 6 months.
Treatment: vCare Intervention (active treatment after 6 months)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older (IGNITE)
- Plain-language title
- Digital program for weight loss and depression in adults over 50Generated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06636058, who can take part
- Record updated
- 18 August 2026